Pinealon vs Selank
Both Pinealon and Selank are used for cognitive. Here's how their evidence, dosing, and regulatory status actually compare.
Pinealon
Evidence CPinealon (EDR)
A short tripeptide developed in Russia for cognitive aging and oxidative stress. Limited Western clinical evidence.
View full Pinealon profile →Selank
Evidence BSelank (TP-7)
A synthetic analog of tuftsin with anxiolytic and nootropic properties. Modulates GABA and serotonin systems to reduce anxiety without sedation.
View full Selank profile →Side-by-Side
| Attribute | Pinealon | Selank |
|---|---|---|
| Evidence Grade | C | B |
| FDA Status | Not FDA-approved — Russian-origin research peptide | Not FDA-approved in US — approved in Russia as anxiolytic |
| Typical Dose | 5–10 mg daily for 10–20 days (subcutaneous, cycled) | 200–400 mcg intranasal, evening |
| Clinics Indexed | 9 | 72 |
| Categories | cognitive, longevity | cognitive, anxiety |
Key reported benefits — Pinealon
- ✓Cognitive function (preclinical)
- ✓Reduced oxidative damage
- ✓Sleep/circadian effects
Key reported benefits — Selank
- ✓Anxiety reduction
- ✓Stress resilience
- ✓Cognitive clarity
- ✓Immune modulation
Educational use only
This comparison is for educational purposes and not medical advice. Peptide selection should be made with a licensed medical professional based on your individual goals, health history, and current evidence quality.